Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Anelixis Therapeutics, LLC
- Registration Number
- NCT04711226
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Multiple Doses of AT-1501-A201 in Adults With ALS
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Anelixis Therapeutics, LLC
- Target Recruit Count
- 54
- Registration Number
- NCT04322149
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
🇺🇸Texas Neurology, P.A., Dallas, Texas, United States
🇺🇸Barrows Neurological Institute, Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath